Modulation of AhR-mediated CYP1A1 mRNA and EROD activities by 17β-estradiol and dexamethasone in TCDD-induced H411E cells

45Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

TCDD elicits a variety of species- and organ-specific pathological consequences. The differential toxicities are thought to relate to the de novo modulation of TCDD action by endogenous hormones. Previous studies from this laboratory demonstrated a dose-and time-dependent induction of CYP1A1 expression and 7-ethoxyresorufin-O-deethylase (EROD) activities in H4IIE cells by picomolar levels of TCDD treatment. In this study, we examined the hormonal modulation of TCDD-elicited AhR-mediated biochemical responses. Lipid-soluble hormones, 17β-estradiol (E2), diethylstilbestrol (DES), testosterone (T), 5α-dihydrotestosterone (DHT), dexamethasone (DEX), and T3 were studied for their possible interactions with the TCDD-mediated effects. Our results showed that CYP1A1 expression and EROD activities induced by TCDD were potentiated or suppressed, respectively, by DEX or E2/DES treatment. Other tested hormones, however, had no significant effect. Using a receptor antagonist (RU486), DEX-mediated potentiation of TCDD-elicited EROD activity was completely abolished. E2-mediated suppression, however, was not affected by cotreatment with the estrogen receptor antagonists, 4-hydroxytamoxifen or ICI 182780. Taking a step further to dissect the possible mechanisms involved, with the aid of cycloheximide (CHX), DEX-mediated potentiation was found to depend on the posttranscriptional process. The DEX pretreatment study indicated that the potentiation was a time-dependent process. In contrast, E2-mediated suppression did not rely on the synthesis of protein factors. Presumably it might hinder the formation of the activated TCDD/AhR complex and so the subsequent binding on DRE. © Society of Toxicology 2004; all rights reserved.

References Powered by Scopus

The steroid and thyroid hormone receptor superfamily

6911Citations
N/AReaders
Get full text

2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity.

2425Citations
N/AReaders
Get full text

Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats

948Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Cytochrome P450 CYP1A1: Wider roles in cancer progression and prevention

387Citations
N/AReaders
Get full text

NRF2 modulates aryl hydrocarbon receptor signaling: Influence on adipogenesis

288Citations
N/AReaders
Get full text

Induction of Cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: Results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro

185Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Lai, K. P., Wong, M. H., & Wong, C. K. C. (2004, March). Modulation of AhR-mediated CYP1A1 mRNA and EROD activities by 17β-estradiol and dexamethasone in TCDD-induced H411E cells. Toxicological Sciences. https://doi.org/10.1093/toxsci/kfh045

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

47%

Researcher 5

33%

Professor / Associate Prof. 3

20%

Readers' Discipline

Tooltip

Environmental Science 5

31%

Biochemistry, Genetics and Molecular Bi... 5

31%

Agricultural and Biological Sciences 4

25%

Pharmacology, Toxicology and Pharmaceut... 2

13%

Save time finding and organizing research with Mendeley

Sign up for free